Using surveillance of 6 to 9-mm polyps with CT colonography instead of referring them for immediate colonoscopy and polypectomy provides a significant cost-effectiveness edge, according to a study presented Sunday.
Using surveillance of 6 to 9-mm polyps with CT colonography instead of referring them for immediate colonoscopy and polypectomy provides a significant cost-effectiveness edge, according to a study presented Sunday.
Death rates might increase by a small amount with a CTC surveillance strategy, but it would avoid nearly 10,000 colonoscopy referrals and, with them, 10 bowel perforations, possibly including one death, producing an incremental cost-effectiveness ratio of $372,853 per life saved, according to the study led by Dr. Perry J. Pickhardt of the University of Wisconsin-Madison.
The study was among several presented at the session addressing CTC. Two others based on American College of Radiology Imaging Network (ACRIN) 6664 trial data pinpointed which reading styles affect performance and found that polyp size estimates with traditional colonoscopy are consistently greater than those based on CTC.
Pickhardt's study was based on a concentrated hypothetical population of 100,000 60-year-olds with a single 6 to 9-mm polyp. The study included a host of assumptions, but these were collectively conservative in that they tended to overestimate the risk of CTC for surveillance of the small polyps, he said.
The study estimated the five-year risk of death for CTC versus optical colonoscopy in the concentrated cohort as .03 versus .02. In a general screening population, the figures were .0024 for CTC versus .0015 for optical colonoscopy.
Exclusion of large polyps at CTC confers a very low risk for cancer, and aggressive management for the 6 to 9-mm polyps may not be indicated, Pickhardt said. Immediate polypectomy is associated with high costs, additional complications, and low yield, while CTC for polyp identification allows for selective identification of small polyps at risk.
The study examining CTC performance was based on a survey of 15 radiologists who together had read more than 2500 studies for the ACRIN 6664 trial, said Dr. Amy Hara of the Mayo Clinic, who presented the findings.
The study broke them into superior (eight) and average (seven) performers and then looked at the reading characteristics of each. The superior performing group had sensitivity and specificity figures for polyps 10 mm and larger of 96% and 89%, respectively, while the average group had comparable figures of 83% and 82%. For polyps of 5 mm or larger, the sensitivity and specificity figures for the superior group dropped to 84% and 91%, respectively, and for the average group to 71% and 84%.
The superior readers shared other characteristics:
The researchers also concluded that the decision to use 2D or 3D for the primary read does not affect performance nor does the level of experience.
A study at Brown University evaluated polyp size estimates obtained with CTC, optical colonoscopy, and pathology. After adjusting for multiple polyps per patient, the colonoscopy measure was consistently 12% greater than the measure for CTC. The pathology measure was consistently 25% smaller than the one for CTC. The study did not, however, account for shrinkage of the polyp due to dehydration after it was removed from the colon.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.